U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with View All

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
182820 Q3 2022 ANHYDROUS LACTOSE ORAL TABLET, DELAYED RELEASE 3250mg Correction
182821 Q4 2022 ANHYDROUS LACTOSE ORAL TABLET, DELAYED RELEASE 1083mg Correction
182822 Q3 2022 CHERRY ORAL SOLUTION 233mg Correction
182823 Q4 2022 FLAVOR CHERRY FT-9496 ORAL SOLUTION 200mg Correction
182824 Q4 2022 HYDROXYPROPYL CELLULOSE (90000 WAMW) BUCCAL FILM, SOLUBLE 292mg Correction
182825 Q4 2022 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM, SOLUBLE 292mg Correction
182826 Q3 2022 HYPROMELLOSE ORAL POWDER, FOR SUSPENSION 150.00 mg Correction
182827 Q4 2022 HYPROMELLOSE ORAL POWDER, FOR SUSPENSION 65.00 mg/ 5.00 ml Correction
182828 Q3 2022 HYPROMELLOSE ORAL SOLUTION 21.90 mg/ 5.00 ml Correction
182829 Q4 2022 HYPROMELLOSE ORAL SOLUTION 3.70 mg/ 1.00 ml Correction
182830 Q3 2022 HYPROMELLOSE ORAL SUSPENSION 1832mg Correction
182831 Q4 2022 HYPROMELLOSE ORAL SUSPENSION 305mg Correction
182832 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE 89mg Correction
182833 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED ORAL CAPSULE 89mg Correction
182834 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE, DELAYED RELEASE 104mg Correction
182835 Q4 2022 Hypromellose acetate succinate 12070923 (3 mPa.s) ORAL CAPSULE, DELAYED RELEASE 104mg Correction
182836 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL CAPSULE, EXTENDED RELEASE 67mg Correction
182837 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED ORAL CAPSULE, EXTENDED RELEASE 67mg Correction
182838 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL GRANULE 92mg Correction
182839 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED ORAL GRANULE 92mg Correction
182840 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL TABLET 4480mg Correction
182841 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED ORAL TABLET 4480mg Correction
182842 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL TABLET, DELAYED RELEASE 2040mg Correction
182843 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED ORAL TABLET, DELAYED RELEASE 2040mg Correction
182844 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE ORAL TABLET, EXTENDED RELEASE 29.00 mg Correction
182845 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED ORAL TABLET, EXTENDED RELEASE 29.00 mg Correction
182846 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MM2/S) ORAL TABLET, DELAYED RELEASE 1800mg Correction
182847 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S) ORAL TABLET, DELAYED RELEASE 1800mg Correction
182848 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S) ORAL CAPSULE, DELAYED RELEASE 99mg Correction
182849 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S) ORAL CAPSULE, DELAYED RELEASE 99mg Correction
182850 Q3 2022 MANNITOL ORAL POWDER 4663mg Correction
182851 Q4 2022 MANNITOL ORAL POWDER 4352mg Correction
182852 Q3 2022 NIACINAMIDE TOPICAL GEL 25mg Correction
182853 Q4 2022 NIACINAMIDE TOPICAL GEL 1.25 %w/w Correction
182854 Q3 2022 PEG-32 HYDROGENATED PALM GLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 8mg Correction
182855 Q4 2022 STEAROYL POLYOXYL-32 GLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 8mg Correction
182856 Q3 2022 PETROLATUM OPHTHALMIC OINTMENT 97.00 %w/w Correction
182857 Q4 2022 PETROLATUM OPHTHALMIC OINTMENT 88.40 %w/w Correction
182858 Q3 2022 PHENOXYETHANOL TOPICAL GEL 14mg Correction
182859 Q4 2022 PHENOXYETHANOL TOPICAL GEL 0.70 %w/w Correction
182860 Q3 2022 POLOXAMER 124 TOPICAL GEL 6mg Correction
182861 Q4 2022 POLOXAMER 124 TOPICAL GEL 4mg Correction
182862 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW) ENDOSINUSIAL IMPLANT 1.35 mg Correction
182863 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID ENDOSINUSIAL IMPLANT 1.35 mg Correction
182864 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW) INTRAVITREAL IMPLANT 116.00 mg Correction
182865 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID INTRAVITREAL IMPLANT 116.00 mg Correction
182866 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW) INTRAVITREAL INJECTION 116.00 mg Correction
182867 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID INTRAVITREAL INJECTION 116.00 mg Correction
182868 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW) SUBCUTANEOUS INJECTION, SOLUTION 533.00 mg Correction
182869 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID SUBCUTANEOUS INJECTION, SOLUTION 533.00 mg Correction
182870 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW) SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE 48mg Correction
182871 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 63000 ACID SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE 37mg Correction
182872 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW) INTRAMUSCULAR INJECTION 60.70 mg Correction
182873 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 63000 ACID INTRAMUSCULAR INJECTION 60.70 mg Correction
182874 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW) SUBCUTANEOUS IMPLANT 16.20 mg Correction
182875 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 63000 ACID SUBCUTANEOUS IMPLANT 16mg Correction
182876 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (75:25; 20000 MW) INTRAMUSCULAR INJECTION 145mg Correction
182877 Q4 2022 DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID INTRAMUSCULAR INJECTION 145mg Correction
182878 Q3 2022 POLYSORBATE 80 RECTAL SOLUTION 840mg Correction
182879 Q4 2022 POLYSORBATE 80 RECTAL SOLUTION 315mg Correction
182880 Q3 2022 POLYVINYL ALCOHOL ORAL TABLET, ORALLY DISINTEGRATING 10mg Correction
182881 Q4 2022 POLYVINYL ALCOHOL ORAL TABLET, ORALLY DISINTEGRATING 6mg Correction
182882 Q3 2022 PROPYLENE GLYCOL ORAL POWDER 330mg Correction
182883 Q4 2022 PROPYLENE GLYCOL ORAL POWDER 55.00 mg Correction
182884 Q3 2022 SODIUM ACETATE INTRAVENOUS INJECTION 984mg Correction
182885 Q4 2022 SODIUM ACETATE INTRAVENOUS INJECTION 56mg Correction
182886 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL-2000)-DISTEAROYL-RAC-GLYCEROPHOSPHOETHANOLAMINE INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 0.32 %w/v Correction
182887 Q4 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 0.32 %w/v Correction
182888 Q3 2022 SORBITAN MONOOLEATE TOPICAL GEL 6mg Correction
182889 Q4 2022 SORBITAN MONOOLEATE TOPICAL GEL 4mg Correction
182890 Q3 2022 SORBITAN MONOSTEARATE TOPICAL CREAM, AUGMENTED 2.00 %w/w Correction
182891 Q4 2022 SORBITAN MONOSTEARATE TOPICAL CREAM, AUGMENTED 0.75 %w/w Correction
182892 Q3 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 51mg Correction
182893 Q4 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 25mg Correction
182894 Q3 2022 STARCH, CORN BUCCAL TABLET 16.60 mg Correction
182895 Q4 2022 STARCH 1500, PREGELATINIZED BUCCAL TABLET 9mg Correction
182896 Q3 2022 STARCH, CORN ORAL CAPSULE 5785mg Correction
182897 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE 5785mg Correction
182898 Q3 2022 STARCH, CORN ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
182899 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
182900 Q3 2022 STARCH, CORN ORAL CAPSULE, DELAYED RELEASE 216mg Correction
182901 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, DELAYED RELEASE 216mg Correction
182902 Q3 2022 STARCH, CORN ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
182903 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
182904 Q3 2022 STARCH, CORN ORAL CONCENTRATE NA Correction
182905 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CONCENTRATE NA Correction
182906 Q3 2022 STARCH, CORN ORAL DROPS NA Correction
182907 Q4 2022 STARCH 1500, PREGELATINIZED ORAL DROPS NA Correction
182908 Q3 2022 STARCH, CORN ORAL PASTILLE NA Correction
182909 Q4 2022 STARCH 1500, PREGELATINIZED ORAL PASTILLE NA Correction
182910 Q3 2022 STARCH, CORN ORAL POWDER, FOR SUSPENSION 34mg Correction
182911 Q4 2022 STARCH 1500, PREGELATINIZED ORAL POWDER, FOR SUSPENSION 34mg Correction
182912 Q3 2022 STARCH, CORN ORAL SUSPENSION 900mg Correction
182913 Q4 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION 900mg Correction
182914 Q3 2022 STARCH, CORN ORAL SUSPENSION/ DROPS 90mg Correction
182915 Q4 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION/ DROPS 90mg Correction
182916 Q3 2022 STARCH, CORN ORAL TABLET 1116mg Correction
182917 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET 1116mg Correction
182918 Q3 2022 STARCH, CORN ORAL TABLET, CHEWABLE 180mg Correction
182919 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, CHEWABLE 180mg Correction
182920 Q3 2022 STARCH, CORN ORAL TABLET, COATED 256mg Correction
182921 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, COATED 256mg Correction
182922 Q3 2022 STARCH, CORN ORAL TABLET, DELAYED RELEASE 240mg Correction
182923 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, DELAYED RELEASE 130mg Correction
182924 Q3 2022 STARCH, CORN ORAL TABLET, EXTENDED RELEASE 184mg Correction
182925 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, EXTENDED RELEASE 184mg Correction
182926 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED 696mg Correction
182927 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED 696mg Correction
182928 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg Correction
182929 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg Correction
182930 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
182931 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
182932 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 10mg Correction
182933 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 21mg Correction
182934 Q3 2022 STARCH, CORN SUBLINGUAL TABLET 409mg Correction
182935 Q4 2022 STARCH 1500, PREGELATINIZED SUBLINGUAL TABLET 409mg Correction
182936 Q3 2022 SUCRALOSE NASAL SPRAY, METERED 358mg Correction
182937 Q4 2022 SUCRALOSE NASAL SPRAY, METERED 2mg Correction
182938 Q3 2022 TOCOPHEROL ORAL CAPSULE 4.00 mg Correction
182939 Q4 2022 TOCOPHEROL ORAL CAPSULE NA Correction
182940 Q3 2022 TRISODIUM CITRATE DIHYDRATE ORAL SUSPENSION 4950mg Correction
182941 Q4 2022 TRISODIUM CITRATE DIHYDRATE ORAL SUSPENSION 947mg Correction
182942 Q4 2022 ADIPIC ACID VAGINAL TABLET 57.00 mg Deletion
182943 Q4 2022 ANHYDROUS CITRIC ACID ORAL LIQUID, EXTENDED RELEASE 5.18 mg/ 1.00 ml 62mg Deletion
182944 Q4 2022 ANHYDROUS TRISODIUM CITRATE ORAL LIQUID, EXTENDED RELEASE 3.90 mg/ 1.00 ml 47mg Deletion
182945 Q4 2022 CARBOMER HOMOPOLYMER RECTAL ENEMA NA Deletion
182946 Q4 2022 CELLULOSE ACETATE CA-398-10 ORAL TABLET 20.93 mg Deletion
182947 Q4 2022 COMPRESSIBLE SUGAR ORAL LIQUID, EXTENDED RELEASE 145.50 mg/ 1.00 ml 1746mg Deletion
182948 Q4 2022 CROSPOVIDONE ORAL TABLET, COATED PARTICLES 130.00 mg 1040mg Deletion
182949 Q4 2022 D&C YELLOW NO. 10 ORAL SUSPENSION/ DROPS NA Deletion
182950 Q4 2022 DISTEAROYLPHOSPHATIDYLCHOLINE, DL- INTRAVENOUS INJECTION 0.68 %w/v Deletion
182951 Q4 2022 ETHYLCELLULOSE (10 MPA.S) ORAL LIQUID, EXTENDED RELEASE 4.17 mg/ 1.00 ml 50mg Deletion
182952 Q4 2022 ETHYLCELLULOSE (20 MPA.S) ORAL POWDER 298.50 mg Deletion
182953 Q3 2022 FLAVOR GRAPE 61.13252 ORAL SYRUP 2.00 mg/ 1.00 ml 20mg Deletion
182954 Q4 2022 GLYCINE ORAL SUSPENSION/ DROPS NA Deletion
182955 Q4 2022 HYPROMELLOSE VAGINAL TABLET, FILM COATED 54.21 mg Deletion
182956 Q4 2022 HYPROMELLOSE 2208 (15000 MPA.S) BUCCAL TABLET, EXTENDED RELEASE 17.25 mg Deletion
182957 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S) ORAL CAPSULE, EXTENDED RELEASE 56.55 mg 57mg Deletion
182958 Q4 2022 HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S) ORAL TABLET, EXTENDED RELEASE 9.92 mg Deletion
182959 Q4 2022 ISOPROPYL PALMITATE TOPICAL CREAM, AUGMENTED 4.00 %w/w Deletion
182960 Q4 2022 LACTOSE MONOHYDRATE VAGINAL TABLET, FILM COATED 17.90 mg Deletion
182961 Q4 2022 MAGNESIUM SILICATE ORAL TABLET, COATED PARTICLES 30.00 mg 180mg Deletion
182962 Q4 2022 MAGNESIUM STEARATE BUCCAL TABLET, EXTENDED RELEASE 0.58 mg 1mg Deletion
182963 Q4 2022 MAGNESIUM STEARATE ORAL TABLET, COATED PARTICLES 7.00 mg 42mg Deletion
182964 Q4 2022 MAGNESIUM STEARATE VAGINAL TABLET, FILM COATED 0.40 mg Deletion
182965 Q4 2022 MEDIUM-CHAIN TRIGLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 3.08 mg 5mg Deletion
182966 Q4 2022 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A ORAL TABLET, COATED PARTICLES 27.90 mg 167mg Deletion
182967 Q4 2022 MICROCRYSTALLINE CELLULOSE BUCCAL TABLET, EXTENDED RELEASE 18.04 mg Deletion
182968 Q4 2022 MICROCRYSTALLINE CELLULOSE ORAL TABLET, COATED PARTICLES 283.60 mg 2269mg Deletion
182969 Q4 2022 MILK PROTEIN CONCENTRATE BUCCAL TABLET, EXTENDED RELEASE 23.00 mg 23mg Deletion
182970 Q4 2022 OLEYL ALCOHOL TOPICAL CREAM, AUGMENTED 2.00 %w/w Deletion
182971 Q4 2022 OPACODE S-1-8106 BLACK ORAL TABLET, EXTENDED RELEASE NA Deletion
182972 Q4 2022 OPADRY YS-1-10533A ORAL TABLET 8.16 mg Deletion
182973 Q4 2022 OPADRY YS-1-10533A ORAL TABLET, EXTENDED RELEASE 40.00 mg 80mg Deletion
182974 Q4 2022 POLOXAMER 188 ORAL LIQUID, EXTENDED RELEASE 0.50 mg/ 1.00 ml 6mg Deletion
182975 Q4 2022 POLYESTER RAYON TRANSDERMAL SYSTEM 96.50 mg Deletion
182976 Q4 2022 POLYETHYLENE GLYCOL 6000 VAGINAL TABLET, FILM COATED 0.06 mg Deletion
182977 Q4 2022 POLYOXYL 20 CETOSTEARYL ETHER TOPICAL CREAM, AUGMENTED 3.00 %w/w Deletion
182978 Q4 2022 POLYVINYL ALCOHOL (108000 MW) ORAL TABLET 38.27 mg Deletion
182979 Q4 2022 POLYVINYL ALCOHOL (108000 MW) ORAL TABLET, EXTENDED RELEASE 11.58 mg 116mg Deletion
182980 Q4 2022 POVIDONE K30 BUCCAL TABLET, EXTENDED RELEASE 0.50 mg 1mg Deletion
182981 Q4 2022 POVIDONE K30 ORAL LIQUID, EXTENDED RELEASE 1.03 mg/ 1.00 ml 12mg Deletion
182982 Q4 2022 PROPYLENE GLYCOL ORAL TABLET, COATED PARTICLES 4.20 mg 34mg Deletion
182983 Q4 2022 SILICON DIOXIDE BUCCAL TABLET, EXTENDED RELEASE 0.46 mg Deletion
182984 Q4 2022 SILICON DIOXIDE ORAL LIQUID, EXTENDED RELEASE 2.03 mg/ 1.00 ml 24mg Deletion
182985 Q4 2022 SILICON DIOXIDE ORAL TABLET, COATED PARTICLES 25.00 mg/ 5.00 ml 200mg Deletion
182986 Q4 2022 SODIUM BENZOATE ORAL LIQUID, EXTENDED RELEASE 2.00 mg/ 1.00 ml 24mg Deletion
182987 Q4 2022 SODIUM BICARBONATE VAGINAL TABLET 43.00 mg Deletion
182988 Q4 2022 SODIUM LAURYL SULFATE BUCCAL TABLET, EXTENDED RELEASE 5.18 mg Deletion
182989 Q3 2022 SODIUM LAURYL SULFATE VAGINAL TABLET 5.00 mg Deletion
182990 Q4 2022 SODIUM PHOSPHATE, MONOBASIC BUCCAL FILM 0.47 mg Deletion
182991 Q4 2022 SODIUM POLYSTYRENE SULFONATE ORAL LIQUID, EXTENDED RELEASE 14.90 mg/ 1.00 ml 179mg Deletion
182992 Q4 2022 SODIUM POLYSTYRENE SULFONATE ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 43.75 mg 44mg Deletion
182993 Q4 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, COATED PARTICLES 10.00 mg 60mg Deletion
182994 Q4 2022 STARCH, CORN ORAL LIQUID, EXTENDED RELEASE 9.38 mg/ 1.00 ml 113mg Deletion
182995 Q3 2022 STARCH, CORN VAGINAL TABLET 49 mg 300mg Deletion
182996 Q4 2022 STARCH, CORN VAGINAL TABLET, FILM COATED 8.00 mg 8mg Deletion
182997 Q4 2022 SUCRALOSE ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 6.00 mg 6mg Deletion
182998 Q4 2022 SUCROSE ORAL LIQUID, EXTENDED RELEASE 0.80 mg/ 1.00 ml 10mg Deletion
182999 Q4 2022 TALC ORAL LIQUID, EXTENDED RELEASE 3.83 mg/ 1.00 ml 46mg Deletion
183000 Q4 2022 TALC ORAL TABLET, COATED PARTICLES 6.50 mg 39mg Deletion
183001 Q4 2022 TRIETHYL CITRATE ORAL LIQUID, EXTENDED RELEASE 0.42 mg/ 1.00 ml 5mg Deletion
183002 Q4 2022 XANTHAN GUM ORAL LIQUID, EXTENDED RELEASE 4.17 mg/ 1.00 ml 50mg Deletion
183003 Q3 2022 ADIPIC ACID VAGINAL INSERT 57.00 mg MDE Replacement
183004 Q4 2022 ADIPIC ACID VAGINAL INSERT 171mg MDE Replacement
183005 Q3 2022 AMMONIUM ACETATE INTRAMUSCULAR INJECTION 0.80 %w/v MDE Replacement
183006 Q4 2022 AMMONIUM ACETATE INTRAMUSCULAR INJECTION 160mg MDE Replacement
183007 Q3 2022 AMMONIUM ACETATE INTRAVENOUS INJECTION 0.80 %w/v MDE Replacement
183008 Q4 2022 AMMONIUM ACETATE INTRAVENOUS INJECTION 160mg MDE Replacement
183009 Q3 2022 AMMONIUM SULFATE INTRAVENOUS INJECTABLE, LIPOSOMAL 0.20 %w/v MDE Replacement
183010 Q4 2022 AMMONIUM SULFATE INTRAVENOUS INJECTABLE, LIPOSOMAL 81mg MDE Replacement
183011 Q3 2022 ANHYDROUS CITRIC ACID INTRAVENOUS INJECTION, SOLUTION 0.53 %w/v MDE Replacement
183012 Q4 2022 ANHYDROUS CITRIC ACID INTRAVENOUS INJECTION, SOLUTION 540mg MDE Replacement
183013 Q3 2022 ANHYDROUS CITRIC ACID ORAL SUSPENSION 720.00 mg MDE Replacement
183014 Q4 2022 ANHYDROUS CITRIC ACID ORAL SUSPENSION 300mg MDE Replacement
183015 Q3 2022 ANHYDROUS CITRIC ACID ORAL SUSPENSION/ DROPS 2.50 mg/ 1.00 ml MDE Replacement
183016 Q4 2022 ANHYDROUS CITRIC ACID ORAL SUSPENSION/ DROPS 14mg MDE Replacement
183017 Q3 2022 ASCORBIC ACID TOPICAL GEL 0.30 %w/w MDE Replacement
183018 Q4 2022 ASCORBIC ACID TOPICAL GEL 3mg MDE Replacement
183019 Q3 2022 BENZYL ALCOHOL INTRAMUSCULAR INJECTION, SUSPENSION 0.92 %w/v MDE Replacement
183020 Q4 2022 BENZYL ALCOHOL INTRAMUSCULAR INJECTION, SUSPENSION 40mg MDE Replacement
183021 Q3 2022 BENZYL ALCOHOL SOFT TISSUE INJECTION, SUSPENSION 0.92 %w/v MDE Replacement
183022 Q4 2022 BENZYL ALCOHOL SOFT TISSUE INJECTION, SUSPENSION 40mg MDE Replacement
183023 Q3 2022 BENZYL ALCOHOL SUBCONJUNCTIVAL INJECTION 0.95 %w/v MDE Replacement
183024 Q4 2022 BENZYL ALCOHOL SUBCONJUNCTIVAL INJECTION 252mg MDE Replacement
183025 Q3 2022 BUTYLATED HYDROXYANISOLE TOPICAL GEL 0.05 %w/w MDE Replacement
183026 Q4 2022 BUTYLATED HYDROXYANISOLE TOPICAL GEL 3mg MDE Replacement
183027 Q3 2022 CALCIUM SILICATE ORAL TABLET, ORALLY DISINTEGRATING 75.00 mg MDE Replacement
183028 Q4 2022 CALCIUM SILICATE ORAL TABLET, ORALLY DISINTEGRATING 600mg MDE Replacement
183029 Q3 2022 CETOSTEARYL ALCOHOL TOPICAL CREAM 12.00 %w/w MDE Replacement
183030 Q4 2022 CETOSTEARYL ALCOHOL TOPICAL CREAM 108mg MDE Replacement
183031 Q3 2022 CETYL ALCOHOL ORAL TABLET, EXTENDED RELEASE 44.00 mg MDE Replacement
183032 Q4 2022 CETYL ALCOHOL ORAL TABLET, EXTENDED RELEASE 132mg MDE Replacement
183033 Q3 2022 CHLOROBUTANOL INTRAVENOUS INJECTION 0.57 %w/v MDE Replacement
183034 Q4 2022 CHLOROBUTANOL INTRAVENOUS INJECTION 25mg MDE Replacement
183035 Q3 2022 CITRIC ACID MONOHYDRATE INTRAVENOUS INJECTION, SOLUTION 5.00 %w/v MDE Replacement
183036 Q4 2022 CITRIC ACID MONOHYDRATE INTRAVENOUS INJECTION, SOLUTION 180mg MDE Replacement
183037 Q3 2022 COCO DIETHANOLAMIDE TOPICAL CREAM 4.00 %w/w MDE Replacement
183038 Q4 2022 COCO DIETHANOLAMIDE TOPICAL CREAM 30mg MDE Replacement
183039 Q3 2022 D&C RED NO. 33 ORAL CAPSULE 0.39 mg MDE Replacement
183040 Q4 2022 D&C RED NO. 33 ORAL CAPSULE 1mg MDE Replacement
183041 Q3 2022 DIMETHYL SULFOXIDE TOPICAL SOLUTION 45.50 %w/w MDE Replacement
183042 Q4 2022 DIMETHYL SULFOXIDE TOPICAL SOLUTION 3640mg MDE Replacement
183043 Q3 2022 DYE GREEN LB-820 ORAL TABLET 0.60 mg MDE Replacement
183044 Q4 2022 DYE GREEN LB-820 ORAL TABLET 2mg MDE Replacement
183045 Q3 2022 EDETATE CALCIUM DISODIUM INTRAVENOUS INJECTION 2.16 mg MDE Replacement
183046 Q4 2022 EDETATE CALCIUM DISODIUM INTRAVENOUS INJECTION 23mg MDE Replacement
183047 Q3 2022 FD&C BLUE NO. 1 ORAL CAPSULE, EXTENDED RELEASE 1.32 mg MDE Replacement
183048 Q4 2022 FD&C BLUE NO. 1 ORAL CAPSULE, EXTENDED RELEASE 1mg MDE Replacement
183049 Q3 2022 FD&C BLUE NO. 2--ALUMINUM LAKE ORAL TABLET, ORALLY DISINTEGRATING 4.70 mg MDE Replacement
183050 Q4 2022 FD&C BLUE NO. 2--ALUMINUM LAKE ORAL TABLET, ORALLY DISINTEGRATING 38mg MDE Replacement
183051 Q3 2022 FD&C GREEN NO. 3 ORAL TABLET 10.00 mg MDE Replacement
183052 Q4 2022 FD&C GREEN NO. 3 ORAL TABLET 240mg MDE Replacement
183053 Q3 2022 FLAVOR RASPBERRY 28106 ORAL SUSPENSION/ DROPS 5.00 mg/ 1.00 ml MDE Replacement
183054 Q4 2022 FLAVOR RASPBERRY 28106 ORAL SUSPENSION/ DROPS 38mg MDE Replacement
183055 Q3 2022 GLYCERIN ORAL CONCENTRATE 750.00 mg/ 1.00 ml MDE Replacement
183056 Q4 2022 GLYCERIN ORAL CONCENTRATE 1800mg MDE Replacement
183057 Q3 2022 GLYCERIN ORAL SUSPENSION/ DROPS 250.00 mg/ 2.50 ml MDE Replacement
183058 Q4 2022 GLYCERIN ORAL SUSPENSION/ DROPS 375mg MDE Replacement
183059 Q3 2022 HEXYLENE GLYCOL TOPICAL GEL 2.00 %w/w MDE Replacement
183060 Q4 2022 HEXYLENE GLYCOL TOPICAL GEL 130mg MDE Replacement
183061 Q3 2022 HIGH DENSITY POLYETHYLENE TRANSDERMAL FILM, EXTENDED RELEASE 85.00 mg MDE Replacement
183062 Q4 2022 HIGH DENSITY POLYETHYLENE TRANSDERMAL FILM, EXTENDED RELEASE 85mg MDE Replacement
183063 Q3 2022 HISTIDINE INTRAVENOUS INJECTABLE, LIPOSOMAL 0.16 %w/v MDE Replacement
183064 Q4 2022 HISTIDINE INTRAVENOUS INJECTABLE, LIPOSOMAL 63mg MDE Replacement
183065 Q3 2022 HYDROCHLORIC ACID INTRAMUSCULAR INJECTION, SOLUTION 1.10 %w/v MDE Replacement
183066 Q4 2022 HYDROCHLORIC ACID INTRAMUSCULAR INJECTION, SOLUTION 8mg MDE Replacement
183067 Q3 2022 HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE INTRAVENOUS INJECTABLE, LIPOSOMAL 213.00 mg MDE Replacement
183068 Q4 2022 HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE INTRAVENOUS INJECTABLE, LIPOSOMAL 388mg MDE Replacement
183069 Q3 2022 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) ORAL SOLUTION 7.50 mg/ 1.00 ml MDE Replacement
183070 Q4 2022 HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) ORAL SOLUTION 225mg MDE Replacement
183071 Q3 2022 HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID INTRAVENOUS INJECTION 0.41 %w/v MDE Replacement
183072 Q4 2022 HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID INTRAVENOUS INJECTION 41mg MDE Replacement
183073 Q3 2022 HYDROXYPROPYL CELLULOSE (110000 WAMW) ORAL TABLET, EXTENDED RELEASE 150.00 mg MDE Replacement
183074 Q4 2022 HYDROXYPROPYL CELLULOSE (110000 WAMW) ORAL TABLET, EXTENDED RELEASE 356mg MDE Replacement
183075 Q3 2022 HYPROMELLOSE 2910 (6 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 16.76 mg MDE Replacement
183076 Q4 2022 HYPROMELLOSE 2910 (6 MPA.S) ORAL TABLET, FILM COATED, EXTENDED RELEASE 8mg MDE Replacement
183077 Q3 2022 LACTOSE MONOHYDRATE VAGINAL INSERT 210.00 mg MDE Replacement
183078 Q4 2022 LACTOSE MONOHYDRATE VAGINAL INSERT 630mg MDE Replacement
183079 Q3 2022 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE ORAL TABLET, FILM COATED 40.00 mg MDE Replacement
183080 Q4 2022 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE ORAL TABLET, FILM COATED 40mg MDE Replacement
183081 Q3 2022 MAGNESIUM STEARATE VAGINAL INSERT 23.00 mg MDE Replacement
183082 Q4 2022 MAGNESIUM STEARATE VAGINAL INSERT 69mg MDE Replacement
183083 Q3 2022 MANNITOL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 220.50 mg MDE Replacement
183084 Q4 2022 MANNITOL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 658mg MDE Replacement
183085 Q3 2022 METHYLPARABEN ORAL POWDER, FOR SUSPENSION 5.00 mg/ 5.00 ml MDE Replacement
183086 Q4 2022 METHYLPARABEN ORAL POWDER, FOR SUSPENSION 5mg MDE Replacement
183087 Q3 2022 MICROCRYSTALLINE CELLULOSE ORAL TABLET 89.60 mg MDE Replacement
183088 Q4 2022 MICROCRYSTALLINE CELLULOSE ORAL TABLET 460mg MDE Replacement
183089 Q3 2022 MONOBASIC POTASSIUM PHOSPHATE SUBCUTANEOUS INJECTION 0.27 %w/v MDE Replacement
183090 Q4 2022 MONOBASIC POTASSIUM PHOSPHATE SUBCUTANEOUS INJECTION 8mg MDE Replacement
183091 Q3 2022 MONOTHIOGLYCEROL INTRAVENOUS INJECTION, SOLUTION 0.01 %w/v MDE Replacement
183092 Q4 2022 MONOTHIOGLYCEROL INTRAVENOUS INJECTION, SOLUTION 158mg MDE Replacement
183093 Q4 2022 OLEYL ALCOHOL TOPICAL CREAM 10.00 %w/w MDE Replacement
183094 Q4 2022 OLEYL ALCOHOL TOPICAL CREAM 20mg MDE Replacement
183095 Q3 2022 OPADRY II 31F58914 WHITE ORAL TABLET 23.00 mg MDE Replacement
183096 Q4 2022 OPADRY II 31F58914 WHITE ORAL TABLET 92mg MDE Replacement
183097 Q3 2022 OPADRY II Y-19-7483 CLEAR ORAL CAPSULE, EXTENDED RELEASE 5.74 mg MDE Replacement
183098 Q4 2022 OPADRY II Y-19-7483 CLEAR ORAL CAPSULE, EXTENDED RELEASE 17mg MDE Replacement
183099 Q3 2022 OPADRY OY-52945 YELLOW ORAL TABLET, FILM COATED 11.95 mg MDE Replacement
183100 Q4 2022 OPADRY OY-52945 YELLOW ORAL TABLET, FILM COATED 24mg MDE Replacement
183101 Q3 2022 OPADRY OY-LS-37200 BUFF ORAL TABLET 10.05 mg MDE Replacement
183102 Q4 2022 OPADRY OY-LS-37200 BUFF ORAL TABLET 10mg MDE Replacement
183103 Q3 2022 OPADRY YS-3-7031 CLEAR ORAL TABLET 17.37 mg MDE Replacement
183104 Q4 2022 OPADRY YS-3-7031 CLEAR ORAL TABLET 69mg MDE Replacement
183105 Q3 2022 PEG-32 HYDROGENATED PALM GLYCERIDES ORAL CAPSULE 12.60 mg MDE Replacement
183106 Q4 2022 STEAROYL POLYOXYL-32 GLYCERIDES ORAL CAPSULE 164mg MDE Replacement
183107 Q3 2022 POLOXAMER 407 TOPICAL GEL 0.20 %w/w MDE Replacement
183108 Q4 2022 POLOXAMER 407 TOPICAL GEL 13mg MDE Replacement
183109 Q3 2022 POLY(DL-LACTIC-CO-GLYCOLIC ACID), (75:25; 20000 MW) INTRAMUSCULAR INJECTION, POWDER, FOR SUSPENSION 3.31 %w/v MDE Replacement
183110 Q4 2022 DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID INTRAMUSCULAR INJECTION, POWDER, FOR SUSPENSION 11mg MDE Replacement
183111 Q3 2022 POLYSORBATE 40 TOPICAL GEL 0.20 %w/w MDE Replacement
183112 Q4 2022 POLYSORBATE 40 TOPICAL GEL 13mg MDE Replacement
183113 Q3 2022 POVIDONE ORAL CAPSULE, EXTENDED RELEASE 72.00 mg MDE Replacement
183114 Q4 2022 POVIDONE ORAL CAPSULE, EXTENDED RELEASE 120mg MDE Replacement
183115 Q3 2022 POVIDONE K25 ORAL TABLET, FILM COATED, EXTENDED RELEASE 10.70 mg MDE Replacement
183116 Q4 2022 POVIDONE K25 ORAL TABLET, FILM COATED, EXTENDED RELEASE 11mg MDE Replacement
183117 Q3 2022 POVIDONE K30 ORAL SOLUTION 30.50 mg/ 1.00 ml MDE Replacement
183118 Q4 2022 POVIDONE K30 ORAL SOLUTION 90mg MDE Replacement
183119 Q3 2022 POVIDONE K30 VAGINAL INSERT 49.00 mg MDE Replacement
183120 Q4 2022 POVIDONE K30 VAGINAL INSERT 147mg MDE Replacement
183121 Q3 2022 POWDERED CELLULOSE ORAL POWDER, FOR SUSPENSION NA MDE Replacement
183122 Q4 2022 POWDERED CELLULOSE ORAL POWDER, FOR SUSPENSION 1455mg MDE Replacement
183123 Q3 2022 PROPYLENE GLYCOL ORAL CAPSULE, LIQUID FILLED 17.70 mg MDE Replacement
183124 Q4 2022 PROPYLENE GLYCOL ORAL CAPSULE, LIQUID FILLED 42mg MDE Replacement
183125 Q3 2022 PROPYLPARABEN SODIUM ORAL POWDER, FOR SUSPENSION 1.23 mg/ 5.00 ml MDE Replacement
183126 Q4 2022 PROPYLPARABEN SODIUM ORAL POWDER, FOR SUSPENSION 16mg MDE Replacement
183127 Q3 2022 SACCHARIN SODIUM ORAL CONCENTRATE 1.50 mg/ 1.00 ml MDE Replacement
183128 Q4 2022 SACCHARIN SODIUM ORAL CONCENTRATE 6mg MDE Replacement
183129 Q3 2022 SILICON DIOXIDE VAGINAL INSERT 2.50 mg MDE Replacement
183130 Q4 2022 SILICON DIOXIDE VAGINAL INSERT 8mg MDE Replacement
183131 Q3 2022 SIMETHICONE EMULSION TOPICAL CREAM 0.20 %w/w MDE Replacement
183132 Q4 2022 SIMETHICONE EMULSION TOPICAL CREAM 4mg MDE Replacement
183133 Q3 2022 SODIUM ALGINATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 320.00 mg MDE Replacement
183134 Q4 2022 SODIUM ALGINATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 640mg MDE Replacement
183135 Q3 2022 SODIUM BENZOATE ORAL SUSPENSION 278.70 mg MDE Replacement
183136 Q4 2022 SODIUM BENZOATE ORAL SUSPENSION 37mg MDE Replacement
183137 Q3 2022 SODIUM BENZOATE ORAL SUSPENSION/ DROPS 3.00 mg/ 1.00 ml MDE Replacement
183138 Q4 2022 SODIUM BENZOATE ORAL SUSPENSION/ DROPS 15mg MDE Replacement
183139 Q3 2022 SODIUM BICARBONATE VAGINAL INSERT 43.00 mg MDE Replacement
183140 Q4 2022 SODIUM BICARBONATE VAGINAL INSERT 129mg MDE Replacement
183141 Q3 2022 SODIUM CHLORIDE INTRAMUSCULAR INJECTION, SUSPENSION 0.87 %w/v MDE Replacement
183142 Q4 2022 SODIUM CHLORIDE INTRAMUSCULAR INJECTION, SUSPENSION 26mg MDE Replacement
183143 Q3 2022 SODIUM CHLORIDE SOFT TISSUE INJECTION, SUSPENSION 0.22 %w/v MDE Replacement
183144 Q4 2022 SODIUM CHLORIDE SOFT TISSUE INJECTION, SUSPENSION 26mg MDE Replacement
183145 Q3 2022 SODIUM LAURYL SULFATE VAGINAL INSERT 5.00 mg MDE Replacement
183146 Q4 2022 SODIUM LAURYL SULFATE VAGINAL INSERT 15mg MDE Replacement
183147 Q3 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET 96.00 mg MDE Replacement
183148 Q4 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET 96mg MDE Replacement
183149 Q3 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS SUBCUTANEOUS INJECTION 0.66 %w/v MDE Replacement
183150 Q4 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS SUBCUTANEOUS INJECTION 20mg MDE Replacement
183151 Q3 2022 SORBIC ACID ORAL SUSPENSION 5.00 mg/ 5.00 ml MDE Replacement
183152 Q4 2022 SORBIC ACID ORAL SUSPENSION 22mg MDE Replacement
183153 Q3 2022 STARCH, CORN VAGINAL INSERT 210.00 mg MDE Replacement
183154 Q4 2022 STARCH 1500, PREGELATINIZED VAGINAL INSERT 147mg MDE Replacement
183155 Q3 2022 SUCROSE ORAL SUSPENSION/ DROPS 1250.00 mg/ 2.50 ml MDE Replacement
183156 Q4 2022 SUCROSE ORAL SUSPENSION/ DROPS 2250mg MDE Replacement
183157 Q3 2022 SUCROSE STEARATE ORAL CAPSULE, EXTENDED RELEASE 44.57 mg MDE Replacement
183158 Q4 2022 SUCROSE STEARATE ORAL CAPSULE, EXTENDED RELEASE 57mg MDE Replacement
183159 Q3 2022 XANTHAN GUM ORAL SUSPENSION/ DROPS 2.90 mg/ 1.00 ml MDE Replacement
183160 Q4 2022 XANTHAN GUM ORAL SUSPENSION/ DROPS 15mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: October 1, 2022
Database Last Updated: October 19, 2022

Back to Top